338 related articles for article (PubMed ID: 18286348)
1. High prevalence of small intestinal bacterial overgrowth in patients with morbid obesity: a contributor to severe hepatic steatosis.
Sabaté JM; Jouët P; Harnois F; Mechler C; Msika S; Grossin M; Coffin B
Obes Surg; 2008 Apr; 18(4):371-7. PubMed ID: 18286348
[TBL] [Abstract][Full Text] [Related]
2. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
[TBL] [Abstract][Full Text] [Related]
3. Laparoscopic bariatric surgery: what else are we uncovering? Liver pathology and preoperative indicators of advanced liver disease in morbidly obese patients.
Kroh M; Liu R; Chand B
Surg Endosc; 2007 Nov; 21(11):1957-60. PubMed ID: 17479322
[TBL] [Abstract][Full Text] [Related]
4. Hepatic histology in obese patients undergoing bariatric surgery.
Machado M; Marques-Vidal P; Cortez-Pinto H
J Hepatol; 2006 Oct; 45(4):600-6. PubMed ID: 16899321
[TBL] [Abstract][Full Text] [Related]
5. Fatty liver disease: predictors of nonalcoholic steatohepatitis and gallbladder disease in morbid obesity.
Liew PL; Lee WJ; Wang W; Lee YC; Chen WY; Fang CL; Huang MT
Obes Surg; 2008 Jul; 18(7):847-53. PubMed ID: 18459024
[TBL] [Abstract][Full Text] [Related]
6. An assessment of bacterial overgrowth and translocation in the non-alcoholic fatty liver of patients with morbid obesity.
Domper Bardají F; Gil Rendo A; Illescas Fernández-Bermejo S; Patón Arenas R; Hernández Albújar A; Martín Dávila F; Murillo Lázaro C; Sánchez Alonso M; Serrano Dueñas M; Sobrino López A; Ramírez Esteso F; Martín Fernández J
Rev Esp Enferm Dig; 2019 Apr; 111(4):294-300. PubMed ID: 30896956
[TBL] [Abstract][Full Text] [Related]
7. Clinical predictors of different grades of nonalcoholic fatty liver disease.
Júnior WS; Nonino-Borges CB
Obes Surg; 2012 Feb; 22(2):248-52. PubMed ID: 21598007
[TBL] [Abstract][Full Text] [Related]
8. Liver disease symptoms in non-alcoholic fatty liver disease and small intestinal bacterial overgrowth.
Rafiei R; Bemanian M; Rafiei F; Bahrami M; Fooladi L; Ebrahimi G; Hemmat A; Torabi Z
Rom J Intern Med; 2018 Jun; 56(2):85-89. PubMed ID: 29101772
[TBL] [Abstract][Full Text] [Related]
9. Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty.
Luyckx FH; Desaive C; Thiry A; Dewé W; Scheen AJ; Gielen JE; Lefèbvre PJ
Int J Obes Relat Metab Disord; 1998 Mar; 22(3):222-6. PubMed ID: 9539189
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and Predictors of Non-Alcoholic Fatty Liver Disease in Morbidly Obese South Indian Patients Undergoing Bariatric Surgery.
Praveenraj P; Gomes RM; Kumar S; Karthikeyan P; Shankar A; Parthasarathi R; Senthilnathan P; Rajapandian S; Palanivelu C
Obes Surg; 2015 Nov; 25(11):2078-87. PubMed ID: 25835982
[TBL] [Abstract][Full Text] [Related]
11. Portal fibrosis and hepatic steatosis in morbidly obese subjects: A spectrum of nonalcoholic fatty liver disease.
Abrams GA; Kunde SS; Lazenby AJ; Clements RH
Hepatology; 2004 Aug; 40(2):475-83. PubMed ID: 15368453
[TBL] [Abstract][Full Text] [Related]
12. Utility of transient elastography (fibroscan) and impact of bariatric surgery on nonalcoholic fatty liver disease (NAFLD) in morbidly obese patients.
Garg H; Aggarwal S; Shalimar ; Yadav R; Datta Gupta S; Agarwal L; Agarwal S
Surg Obes Relat Dis; 2018 Jan; 14(1):81-91. PubMed ID: 29126863
[TBL] [Abstract][Full Text] [Related]
13. Consequences of Small Intestinal Bacterial Overgrowth in Obese Patients Before and After Bariatric Surgery.
Sabate JM; Coupaye M; Ledoux S; Castel B; Msika S; Coffin B; Jouet P
Obes Surg; 2017 Mar; 27(3):599-605. PubMed ID: 27576576
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of nonalcoholic steatohepatitis in Japanese patients with morbid obesity undergoing bariatric surgery.
Seki Y; Kakizaki S; Horiguchi N; Hashizume H; Tojima H; Yamazaki Y; Sato K; Kusano M; Yamada M; Kasama K
J Gastroenterol; 2016 Mar; 51(3):281-9. PubMed ID: 26314837
[TBL] [Abstract][Full Text] [Related]
15. Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease.
Weiner RA
Dig Dis; 2010; 28(1):274-9. PubMed ID: 20460923
[TBL] [Abstract][Full Text] [Related]
16. IL-6 and IGF-1 are independent prognostic factors of liver steatosis and non-alcoholic steatohepatitis in morbidly obese patients.
García-Galiano D; Sánchez-Garrido MA; Espejo I; Montero JL; Costán G; Marchal T; Membrives A; Gallardo-Valverde JM; Muñoz-Castañeda JR; Arévalo E; De la Mata M; Muntané J
Obes Surg; 2007 Apr; 17(4):493-503. PubMed ID: 17608262
[TBL] [Abstract][Full Text] [Related]
17. The predictive role of parathyroid hormone for non-alcoholic fatty liver disease based on invasive and non-invasive findings in candidates of bariatric surgery.
Jamialahmadi T; Nematy M; Jangjoo A; Goshayeshi L; Abdalla MA; Akhlaghi S; Sathyapalan T; Sahebkar A
Eat Weight Disord; 2022 Mar; 27(2):693-700. PubMed ID: 33999371
[TBL] [Abstract][Full Text] [Related]
18. Histologic spectrum of nonalcoholic fatty liver disease in morbidly obese adolescents.
Xanthakos S; Miles L; Bucuvalas J; Daniels S; Garcia V; Inge T
Clin Gastroenterol Hepatol; 2006 Feb; 4(2):226-32. PubMed ID: 16469684
[TBL] [Abstract][Full Text] [Related]
19. Metabolic syndrome is related to nonalcoholic steatohepatitis in severely obese subjects.
Huang HL; Lin WY; Lee LT; Wang HH; Lee WJ; Huang KC
Obes Surg; 2007 Nov; 17(11):1457-63. PubMed ID: 18219772
[TBL] [Abstract][Full Text] [Related]
20. Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients.
Lassailly G; Caiazzo R; Buob D; Pigeyre M; Verkindt H; Labreuche J; Raverdy V; Leteurtre E; Dharancy S; Louvet A; Romon M; Duhamel A; Pattou F; Mathurin P
Gastroenterology; 2015 Aug; 149(2):379-88; quiz e15-6. PubMed ID: 25917783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
